Metraipolis › archive › dc_11e8a651d4f7

Mendelian randomization analysis links HLA-DR+ CD14- CD16+ monocytes to CCL19-driven ankylosing spondylitis risk — Europe PMC PMID:42116383

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42116383
DOI
10.1097/md.0000000000048687
License (as archived)
solo-consultazione
Archived
2026-11-02T21:28:50.313Z
SHA-256 of the archived text
39aef97e7fad1890491afed0987efd6fa32ee8d29133057c4f359b26f54d20e9
Stable URL of this page
https://metraipolis.com/documento/dc_11e8a651d4f7

How to cite

Mendelian randomization analysis links HLA-DR+ CD14- CD16+ monocytes to CCL19-driven ankylosing spondylitis risk — Europe PMC PMID:42116383 — Europe PMC (en), https://europepmc.org/article/MED/42116383 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11e8a651d4f7 (Metraipolis archive dc_11e8a651d4f7, sha256 39aef97e7fad1890491afed0987efd6fa32ee8d29133057c4f359b26f54d20e9)
BibTeX
@misc{dc11e8a651d4f7,
  title = {Mendelian randomization analysis links HLA-DR+ CD14- CD16+ monocytes to CCL19-driven ankylosing spondylitis risk — Europe PMC PMID:42116383},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42116383},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11e8a651d4f7; sha256 39aef97e7fad1890491afed0987efd6fa32ee8d29133057c4f359b26f54d20e9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42116383. Agents can read the archived copy with the MCP tool read_document.